Short communication: Hospital-based surveillance for HTLV-1/2 infections in Spain

AIDS Research and Human Retroviruses

Volumn 23, Issue 9, 2007, Pages 1075-1077

  Toro, Carlos ^a   Aguilera, Antonio ^b   Caballero, Estrella ^c   Tuset, Concepción ^d   Álvarez, Patricia ^e   García Campello, Marta ^e   Rodríguez Iglesias, Manuel ^f   De Lejarazu, Raúl Ortiz ^g   Eiros, José ^g   Rodriguez, Carmen ^h   Del Romero, Jorge ^h   Benito, Rafael ⁱ   Calderón, Enrique ^j   Santana, Otilia ^k   Amor, Aránzazu ^a   Gómez Hernando, César ^l   García, Juan ^m   Soriano, Vincent ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL XERAL CALDE   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e Servicio de Medicina Interna Enfermedades Infecciosas   (Spain)

^f HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

^g Hospital Clinico   (Spain)

^h CENTRO SANITARIO SANDOVAL   (Spain)

ⁱ HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^j HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^k HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^l HOSPITAL VIRGEN DE LA SALUD   (Spain)

^m Hospital Cristal Pinor   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ARTICLE; ENDEMIC DISEASE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMIGRATION; POPULATION STRUCTURE; PREVALENCE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SPAIN; ADOLESCENT; ADULT; AGED; BLOOD; CHILD; FEMALE; HEALTH SURVEY; HOSPITAL; IMMUNOLOGY; INFANT; MALE; MIDDLE AGED; MIGRATION; PRESCHOOL CHILD; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EMIGRATION AND IMMIGRATION; FEMALE; HOSPITALS; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HTLV-II ANTIBODIES; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; INFANT; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; SPAIN;

EID: 35348906324     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0192     Document Type: Article

References (16)

1. Manns A, Hisada M, and La Grenade L: Human T-lymphotropic virus type I infection. Lancet 1999;353:1951-1958.
2. Roucoux D, and Murphy E: The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev 2004;6:144-154.
3. Proietti F, Carneiro-Proietti A, Catalan-Soares B, and Murphy E: Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005;24:6058-6068.
4. Taylor G, on behalf of the HTLV European Research Network (HERN): The epidemiology and clinical impact of HTLV infections in Europe. AIDS Rev 1999;1:195-204.
5. Soriano V, Gutierrez M, Vallejo A, et al.: Epidemiology of HTLVI infection in Spain. HTLV Spanish Study Group. Int J Epidemiol 1996;25:443-449.
6. Soriano V, Vallejo A, Gutierrez M, et al.: Epidemiology of human T-lymphotropic virus type II (HTLV-II) infection in Spain. HTLV Spanish Study Group. Eur J Epidemiol 1996;12:625-629.
7. HTLV European Research Network: Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. J Acquir Immune Defic Syndr 1996;13:68-77.
8. Toro C, Benito R, Aguilera A, et al.: Infection with human T-lymphotropic virus type I in organ transplant donors and recipients in Spain. J Med Virol 2005;76:268-270.
9. de la Fuente L, Toro C, Soriano T, et al.: HTLV infection among young injection and non-injection heroin users in Spain: Prevalence and correlates. J Clin Virol 2006;35:244-249.
10. Machuca A, Tuset C, Soriano V, et al.: Prevalence of HTLV infection in pregnant women in Spain. Sex Transm Infect 2000;76:366-370.
11. Carneiro-Proietti A, Catalan-Soares B, Castro-Costa C, et al.: HTLV in the Americas: Challenges and perspectives. Rev Panam Salud Publica 2006;19:44-53.
12. Belza M, on behalf of the Spanish Group for the Unlinked Anonymous Survey of HIV Seroprevalence in STD Patients: Prevalence of HIV, HTLV-I and HTLV-II among female sex workers in Spain, 2000-2001. Eur J Epidemiol 2004;19:279-282.
13. Toro C, Rodés B, Poveda E, and Soriano V.: Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor. Transplantation 2003;75:102-104.
14. Nakatsuji Y, Sugai F, Watanabe S, et al.: HTLV-I associated myelopathy manifested after renal transplantation. J Neurol Sci 2000;177:154-156.
15. Tanabe K, Kitani R, Takahashi K, et al.: Long-term results in human T-cell leukaemia virus type 1-positive renal transplant recipients. Transplant Proc 1998;30:3168-3170.
16. Taylor G, Bodeus M, Courtois F, et al.: The seroepidemiology of human T-lymphotropic viruses types I and II in Europe: A prospective study of pregnant women. J Acquir Immune Defic Syndr 2005;38:104-109.